According to the report, the global alpha lipoic acid industry generated $0.7 billion in 2020, and is anticipated to generate $1.4 billion by 2030, witnessing a CAGR of 6.3% from 2021 to 2030. 

Prime determinants of growth  

Robust dietary supplements demand and rise in demand for anti-aging creams drive the growth of the global alpha lipoic acid market. However, side-effects associated with the use of alpha-lipoic acid hinder the market growth. On the other hand, surge in utilization for nerve pain treatment in people with diabetes presents new opportunities in the coming years.  

The R alpha lipoic acid segment to maintain its leadership status throughout the forecast period 

Based on product type, the R alpha lipoic acid segment held the highest market share in 2020, accounting for four-fifths of the global alpha lipoic acid market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, this segment is projected to manifest the highest CAGR of 6.6% from 2021 to 2030. The increasing energy-dense diet and physical inactivity have surged the number of diabetic patients where r alpha-lipoic acid is widely used in neuropathy treatment for reducing pain, numbness, and paresthesia. This is turn, is acting as one of the key drivers responsible for market growth. Another segment discussed in the report is S alpha lipoic acid. 

.The pharmaceuticals segment to maintain its lead position during the forecast period 

Based on application, the pharmaceuticals segment accounted for the largest share in 2020, contributing more than two-fifths of the global alpha lipoic acid market, and is projected to maintain its lead position during the forecast period. This is due the rapid change in lifestyle and energy-dense diet. Moreover, this segment is also expected to portray the largest CAGR of 6.8% from 2021 to 2030, while the dietary supplements segment is expected to have CAGR of 6.1% from 2021 to 2030. 

North America to maintain its dominance by 2030 

Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than one-third of the global alpha lipoic acid market. However, the Asia-Pacific region is expected to witness the fastest CAGR of 7.4% from 2021 to 2030, owing to the utilization of alpha-lipoic acid in sectors such as cosmetics, pharmaceuticals, and others. 

Leading Market Players:- 

  • AlzChem Group AG 
  •  GeroNova Research Inc. 
  •  Haihang Industry 
  •  HiMedia Laboratories 
  •  NOW Foods 
  •  Olon S.p.A 
  •  Rexall Sundown Inc. 
  •  Source Naturals Inc. 
  •  Suzhou Fushilai Pharmaceutical Co. Ltd. 
  • Wellona Pharma